論文・技術情報追加のお知らせ

PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development.

経路および薬物関連表現型を同定するためのPathFX手法に関するベンチマーク調査

対象DB：FAERS

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System.

GLP-1受容体アゴニスト使用と糖尿病性網膜症との関連性評価

対象DB：FAERS

Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase between 2014 and 2017.

欧州における鉄（III）イソマルトシドと鉄キレート剤による重度な過敏反応調査

対象DB：EudraVigilance・VigiBase

Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink.

喘息および高リスク状態の小児および青年におけるインフルエンザ生ワクチン（LAIV）の安全性の評価

対象DB：CPRD

The risk of inflammatory bowel disease in subjects presenting with perianal abscess: findings from the THIN database.

肛門周囲膿瘍患者における炎症性腸疾患のリスク調査

対象DB：THIN

"Vitiligo and major depressive disorder: a bidirectional population-based cohort study".

白斑患者におけるうつ病性障害についての双方向性関係評価

対象DB：THIN